European Society of Cardiology
 
  Login  Home About Us Contact Us Site Map
 Home > ESC Constituent Bodies > Associations > European Association of Echocardiography (EAE) > European Association of Echocardiography Clinical Case Portal > cases
European Association of Echocardiography Clinical Case Portal
cases
Case 143
Case 147
Case 148
Case 149
Case 150
Case 151
Case 154
Case 156
Case 157
Case 159
Case 162
Case 163
Case 164
Case 165
Case 168
Case 169
Case 170
Case 171
Case 172
Case 174
Case 175
Case 176
Case 178
Case 179
Case 180
Case 181
Case 182
Case 184
Case 185
Case 186
Case 188
Case 189
Case 190
Case 191
Case 193
Case 194
Case 197
Case 198
Case 205
Case 206
Case 208
Case 212
Case 214
Case 216
Case 217
Case 218
Case 219
Case 220
Case 222
Case 223
Case 224
Case 225
Case 226
Case 227
Case 228
Case 229
Case 230
Case 231
 
EAE Clinical Case Portal
ESC Guidelines
Scientific and Knowledge Search
ESC Congress Reports

EAE Clinical Case Reports

Print version

Date of publication : 16 October 2006

Topics : Cardiomyopathy
Heart Failure (HF)
Source of embolism

Non-amyloidotic light-chain deposition cardiomyopaty

Daniel Saura, Gonzalo de la Morena, Juan J. Montoya, Federico Soria, Rafael Florenciano & Mariano Valdés-Chávarri.
Servicio de Cardiología. Hospital Universitario Virgen de la Arrixaca. Murcia, Spain.

Case report Summary

Light-chain deposition in myocardium usually manifests as amyloidotic restrictive cardiomyopathy. In rare cases paraproteinemia can deposite as a non-fibrillary infiltrate that does not show typical tintorial attributes of amyloidosis but resembles its clinical features. Clinical suspiction and correct diagnosis are important since early treatment of underlying cell plasma dyscrasia can reverse cardiac dysfunction. We present images from the case of a 47-year-old woman with fatal non-amyloidotic light-chain deposition cardiomyopathy that developed left atrial mechanical dysfunction while in sinus rhythm complicated with systemic arterial embolization.


Patient history prior to current observation :


A 47-year-old woman sustained a 8-month history of heart failure. She had been managed in an outpatient clinic. At symptoms onset, she underwent transthoracic echocardiography that revealed "concentric hypertrophy and normal ventricular function". Initial diagnosis of non-obstructive hypertrophic cardiomyopathy was made, but small doses of propranolol first, and verapamil later resulted in significant worsening of symptoms. Diuretics and vasodilators were started, but heart failure symptoms progressed. She was then referred to our hospital outpatient clinic for evaluation.


Clinical findings on admission, evolution and outcome :

Outpatient work-up in our hospital:
· ECG (fig. 1): Sinus rhythm, nonspecific intraventricular conduction delay and repolarization alterations.
· Chest X-ray (fig. 2): Cardiomegalia, mild bilateral pleural effusion, pulmonary vascular congestion and interstitial oedema.
· Blood tests: Haemogram, coagulation, serum creatinine, thyroid hormones, ferritin and angiotensin-converting enzime were normal. Erytrhocyte sedimentation rate was high at 80 mm/h. Serum electrophoresis showed a monoclonal peak of lambda light-chains, while levels of IgG, IgA and IgM were slightly decreased (fig. 3).
· Urine analysis: Proteinuria (2.1 g/dL). Monoclonal lambda light-chain peak of 3.5 mg/dL (Bence-Jones Proteinuria).
· Transthoracic echocardiography: Concentric (relative wall thickness 0.99) increment of left ventricular mass (113 g/m2). Left ventricular ejection fraction 58%. (fig. 4; fig. 5; fig. 6). Note that fractional shortening (fig. 4 and fig. 5) is well preserved, but longitudinal shortening assessed in fig. 6 is reduced. Left atrial dimensions were normal. Valves had no significant dysfunction. Mild pericardial and left pleural effusions were found. Mitral inflow (fig. 7 showed short E wave deceleration time (120 ms) and a hardly visible atrial contribution. Pulmonary vein flow(fig. 8) showed a marked prevalence of the diastolic component and the absence of retrograde A wave. Both Doppler patterns were consistent with restrictive physiology and left atrial mechanical dysfunction. Pulsed tissue Doppler interrogation of mitral annulus at both its septal and lateral points disclosed E' wave velocity of 6 cm/s, pointing towards restrictive cardiomyopathy rather than constrictive pericarditis.
· Rectal mucose biopsy was negative for Congo red staining.


Discussion & Conclusions :

Evolution and outcome
   Still awaiting results of the above mentioned tests, our patient was admitted due to acute lower limb ischaemia. ECG showed sinus rhythm. Ischaemia improved on heparin, but heart failure worsened despite intensive therapy and our patient died on the fifth day from admission. Autopsy found deposition of extracellular homogeneous eosinophilic material negative for Congo red stain and positive for lambda light-chain immunostaining in myocardium (fig. 9; fig. 10),pancreas, spleen and kidney. Histology did not reveal plasma cell disease in bone marrow or elsewere. Mural thrombi were found in both atria. Recent infarction of embolic pattern were noted in left kidney and spleen.

Conclusions

· Although cardiac amyloidosis is the characteristic expression of paraproteinemia deposition in myocardium, non-amyloidotic light-chain depostion cardiomyopathy should be considered in the differential diagnosis of restrictive cardiomyopathy.
· Its recognition is important since reversibility has been reported after successful treatment of underlying plasma cell dyscrasia.
· Amyloidosis shows typical staining with Congo red. Diagnosis of non-amyloidotic light-chain deposition is confirmed by paraproteinemia demonstration, absence of Congo red staining and positive immunostaining for immunoglobulin light chains in biopsy specimens.
· Nonamyloidotic light-chain deposition cardiomyopathy has been reported to mimic clinical and echocardiographic features of cardiac amyloidosis, including atrial electromechanical dissociation (fig. 1; fig. 7; fig. 8) and embolic events.
· Whether anticoagulation should be instituted in case of left atrial mechanical dysfunction despite electrocardiographic sinus rhythm is debatable. Echocardiography has a role in left atrial electromechanical dissociation diagnosis.


References :
  1. Saura D, Bixquert D, Montoya JJ, Soria F, Bas A, Valdés M. Peripheral Embolism in Nonamyloidotic Light-Chain Deposition Cardiomyopathy. Rev Esp Cardiol 2003; 56: 921-922.
  2. Buxbaum JN, Genega EM, Lazowski P, Kumar A, Tunick PA, Krozon I, et al. Infiltrative nonamyloidotic monoclonal immunoglobulin light chain cardiomyopathy: an underappreciated manifestation of plasma cell dyscrasias. Cardiology 2000;93:220-8.
  3. Nakamura M, Satoh M, Kowada S, Satoh H, Tashiro A, Sato F, et al. Reversible restrictive cardiomyopathy due to light-chain deposition disease. Mayo Clin Proc 2002;77:193-6.
  4. Jego P, Paillard F, Ramee MP, GrosboisB.. Congestive heart failure: revealing light chain deposition disease. Eur J Intern Med 2000; 11:101-3.
  5. Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J 1995;74:541-4.
  6. Garcia MJ, Rodriguez L, Ares M, Griffin BP, Thomas JD, Klein AL. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol. 1996;27:108-114
  Cases related media images
 

Fig. 1

Non-amyloidotic light-chain cardiomyopathy_ECG_Non-specific QRS-T abnormalities

  Non-amyloidotic light-chain cardiomyopathy_ECG_Non-specific QRS-T abnormalities

Fig. 2

Non-amyloidotic light-chain cardiomyopaty _Chest X-ray film: heart failure

  Non-amyloidotic light-chain cardiomyopaty _Chest X-ray film: heart failure

Fig. 3

Serum immunoelectrophoresis: lambda light-chain monoclonal band.

  Serum immunoelectrophoresis: lambda light-chain monoclonal band.

Fig. 4

Non-amyloidotic light-chain cardiomyopathy_TTE_PLAX

  Non-amyloidotic light-chain cardiomyopathy_TTE_PLAX

Fig. 5

Non-amyloidotic light-chain cardiomyopathy_TTE_2D_PSAX

  Non-amyloidotic light-chain cardiomyopathy_TTE_2D_PSAX

Fig. 6

Non-amyloidotic light-chain cardiomyopathy_TTE_2D_AP4C

  Non-amyloidotic light-chain cardiomyopathy_TTE_2D_AP4C

Fig. 7

Non-amyloidotic light-chain cardiomyopathy_TTE_PWD_Restrictive mitral inflow

  Non-amyloidotic light-chain cardiomyopathy_TTE_PWD_Restrictive mitral inflow

Fig. 8

Non-amyloidotic light-chain cardiomyopathy_TTE_Pulmonary vein flow_restrictive pattern

  Non-amyloidotic light-chain cardiomyopathy_TTE_Pulmonary vein flow_restrictive pattern

Fig. 9

Non-amyloidotic light-chain cardiomyopaty_Histology_Myocardium_Congo red staining_No signs of amyloidosis

  Non-amyloidotic light-chain cardiomyopaty_Histology_Myocardium_Congo red staining_No signs of amyloidosis

Fig. 10

Non-amyloidotic light-chain cardiomyopaty_Histology_lambda light-chain immunostaining.

  Non-amyloidotic light-chain cardiomyopaty_Histology_lambda light-chain immunostaining.

Site Map | Contact Us | Terms & Conditions Privacy
 
Copyright © European Society of Cardiology 1997 - 2005 - All rights reserved